ZANUSPERO Trademark

Trademark Overview

On Friday, September 15, 2017, a trademark application was filed for ZANUSPERO with the United States Patent and Trademark Office. The USPTO has given the ZANUSPERO trademark a serial number of 87609610. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by BeiGene, Ltd.. The ZANUSPERO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
zanuspero

General Information

Serial Number87609610
Word MarkZANUSPERO
Filing DateFriday, September 15, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements

Goods and Servicespharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1108
KY
Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1108
KY

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2019EXTENSION 3 GRANTED
Wednesday, September 25, 2019EXTENSION 3 FILED
Wednesday, September 25, 2019TEAS EXTENSION RECEIVED
Wednesday, March 27, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 27, 2019EXTENSION 2 GRANTED
Wednesday, March 27, 2019EXTENSION 2 FILED
Wednesday, March 27, 2019TEAS EXTENSION RECEIVED
Wednesday, February 6, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 6, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, September 25, 2018EXTENSION 1 GRANTED
Tuesday, September 25, 2018EXTENSION 1 FILED
Tuesday, September 25, 2018TEAS EXTENSION RECEIVED
Tuesday, April 3, 2018NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2018NOTICE OF PUBLICATION
Tuesday, December 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2017ASSIGNED TO EXAMINER
Wednesday, September 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 19, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

zanuspero diseases infectious inflammatory autoimmune treatment cancer pharmaceuticals